Thank you very much, Mr. Christopherson.
The issues around the statements about our backlog and the statements around the 15 days have been a source of great concern to me and the other people at this table, because certainly in reading the report and in having a look at the review of how those statements came about and where we find ourselves today, it is not a good place to be. We've struggled with the issue around backlog and the definition of backlog, and unfortunately the person who made those statements is not here today to explain what they meant under those circumstances. But I can assure you that we are not arguing with the fact that the Auditor General has found a backlog, and we are building an action plan to improve it.
One of the things that we experienced, as I said, over the period between 2000 and now was a vast increase in the number of intake and uptake cases, which again has affected our results. As was stated by the Auditor, we did not have the defined and refined data to be able to directly reflect the connection between the issues of the effect of things like the Pickton case and the other increase in DNA intake and our backlog and turnaround result issues. So I have a very difficult time answering that part of your question with any kind of certainty.
With regard to the comment that Deputy Martin made, I'll pass the mike to Deputy Martin for him to offer you an explanation with regard to that, please.